Kusajili – Clinical trials directory

Result of your search per sponsor: Barbara Ludwig, MD

Woman and Man Max 99 years
Barbara Ludwig, MD Update Il y a 4 ans

Reparixin in Pancreatic Islet Transplantation Inhibition of CXCL8 activity might represent a relevant therapeutic target to prevent injury occurring after pancreatic islet transplantation. Reparixin is a novel and specific inhibitor o...

Country Germany, Italy
organs None
Specialty None

Closed trial

More information